TABLE 2.

Characteristics of the seven patients with MBL genotype-producing P. aeruginosa isolates

Patient no.	Age (yr)	Sexa	Diagnosis	Site of infection	Hospital stay prior to BSI (days)	Hospital stay (days)	SAPS score	Previous antibiotic treatment	Response to antibiotic therapy	DNA sequencing result	Outcome
1	46	M	Gastrointestinal disease	Gastrointestinal	8	28	30	Quinolone	Inadequate	IMP-16	Death (related to BSI)
2	63	F	Hematologic malignancy	Catheter	20	32	31	None	Inadequate	IMP-1	Death (related to BSI)
3	61	F	Neurologic disease	Respiratory	41	117	32	Carbapenem	Adequate	IMP-1	Survival
4	71	M	Hematologic malignancy	Respiratory	22	22	56	Cephalosporin	Inadequate	SPM-1	Death (related to BSI)
5	74	M	Renal failure	Catheter	33	72	44	Carbapenem	Adequate	SPM-1	Death (not related to BSI)
6	80	M	Gastrointestinal disease	Gastrointestinal	0	13	37	Cephalosporin	Inadequate	SPM-1	Death (related to BSI)
7	49	F	Hematologic malignancy	Gastrointestinal	21	23	24	Cephalosporin	Inadequate	SPM-1	Death (related to BSI)

^aM, male; F, female.